Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Definition of the Target Population for Xarelto's New Indications in Connection With the VOYAGER PAD Study

NCT04824729 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04824729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04824729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Definition of the Target Population for Xarelto's New Indications in Connection With the VOYAGER PAD Study
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
March 24, 2021
Completion date
January 7, 2022
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease